Manus Ai deal blocked by China’s review office, forcing unwind of $2 billion sale

China's review office retroactively barred Meta’s December acquisition of Manus and ordered the unwinding of the $2 billion Manus Ai deal on April 27.

Published
3 Min Read
Why Did Beijing Kill a $2 Billion AI Deal?

’s office that coordinates the country’s foreign investment security review retroactively prohibited ’s December acquisition of and ordered the parties to unwind the transaction, the office announced on April 27.

The office sits under the National Development and Reform Commission and described Manus as a -based company. Manus launched in 2025 as a general-purpose AI agent and went viral almost instantly. led a $75 million round for the company, which later moved to Singapore in the summer of 2025 and agreed to sell itself to Meta for $2 billion less than six months after leaving China.

For , who has been watching Chinese tech firms move abroad, the episode looked familiar: she said some companies pursue moves to Singapore as an operational tactic and that the relocation was never meant to be a last-minute fix. That strategy — often called Singapore-washing by observers — has been a common way for Chinese startups to position themselves between and U.S. markets.

The numbers make the stakes plain. Manus was backed with a $75 million financing round and then targeted by a $2 billion acquisition. The purchase completed in December, according to the description of the transaction, and Beijing’s review office stepped in months later to block it and demand reversal. Chinese authorities told the parties to unwind the sale.

Officials were likely alarmed by Manus’s work in AI and by the company’s origin in China’s tech ecosystem, two facts that national security reviewers have flagged before. Authorities have shown they do not want firms built on Chinese engineering talent and technology to rebrand abroad and carry innovations with them. Even though Manus reportedly managed to secure approval from Beijing for its move to Singapore, regulators ultimately intervened.

The intervention landed in Singapore, which has been described as a hub for companies and investors trying to navigate the space between Beijing and Washington. Some Chinese startups have long aspired to go global to the United States, and Singapore often operates as a launchpad. Yet the blockage of the Manus sale underlines how red lines drawn by the two capitals can still follow firms that relocate.

The practical friction is obvious. called the Meta deal “quite bold” and warned that anyone in the space would be aware of the risks of incurring Beijing’s wrath. That gap — between a commercial bet to scale globally and the political reality that innovations tied to China remain of interest to Chinese regulators — is where this dispute lives.

Observers called the blocked acquisition another moment when the fantasy of seamless globalization collided with national security politics. For corporate managers and investors, the Manus case will be an instructive example: moving a company’s legal address to Singapore, even after securing some approvals, does not guarantee insulation from Beijing’s security review if the firm’s technology and talent trace back to China.

The immediate consequence is procedural: the parties have been ordered to unwind a $2 billion deal that closed in December. The larger consequence is strategic. The Manus episode is likely to sharpen caution among startups and acquirers considering cross-border deals that touch sensitive technologies, and it will press companies to reckon that regulatory sign-off in one form does not erase national strategic concerns.

Whatever paperwork follows, the episode repositions the business calculus for AI companies born inside China. Manus’s rapid rise — a viral general-purpose agent launched in 2025, major venture backing, relocation to Singapore and a $2 billion sale less than six months after leaving China — now serves as a test case in how national security politics can undo high-profile tech exits.

TAGGED:
Share This Article